Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol on Ocular Hemodynamics in Glaucoma
NCT04596826Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2020
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in Open-angle glaucoma (OAG), sponsored by Medical University of Vienna. Started Nov 2020; status: completed.
02
Drugs
dronabinol
03
Conditions
Open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT04596826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04596826.